120 related articles for article (PubMed ID: 29416612)
1. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.
Zhu H; Wang Y; Song C; Feng Q; Wu J; Zhao S; Gui L; Zhang X; Zhao M; Peng S
Oncotarget; 2018 Jan; 9(1):268-281. PubMed ID: 29416612
[TBL] [Abstract][Full Text] [Related]
2. IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis.
Wu J; Zhu H; Yang G; Wang Y; Wang Y; Zhao S; Zhao M; Peng S
Oncotarget; 2017 Oct; 8(53):91391-91401. PubMed ID: 29207652
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models.
Feng Q; Wang M; Muhtar E; Wang Y; Zhu H
Int J Nanomedicine; 2021; 16():5777-5795. PubMed ID: 34471352
[TBL] [Abstract][Full Text] [Related]
4. A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Peng S
Bioorg Med Chem Lett; 2016 Oct; 26(19):4631-4636. PubMed ID: 27575475
[TBL] [Abstract][Full Text] [Related]
5. Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis.
Chen H; Wang W; Zhang X; Liu S; Wang Y; Zhu H; Wu J; Wang Y; Zhao M; Peng S
Oncotarget; 2018 Aug; 9(63):32119-32133. PubMed ID: 30181803
[TBL] [Abstract][Full Text] [Related]
6.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Gui L; Zhang X; Peng S
Drug Des Devel Ther; 2017; 11():225-239. PubMed ID: 28176928
[TBL] [Abstract][Full Text] [Related]
7. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
[TBL] [Abstract][Full Text] [Related]
8. IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo.
Wu J; Zhu H; Zhao M; Wang Y; Yang G; Wang Y; Zhao S; Gui L; Zhang X; Peng S
J Mater Chem B; 2017 Feb; 5(5):917-927. PubMed ID: 32263869
[TBL] [Abstract][Full Text] [Related]
9. P-selectin and TNF inhibition reduce venous thrombosis inflammation.
Wakefield TW; Strieter RM; Downing LJ; Kadell AM; Wilke CA; Burdick MD; Wrobleski SK; Phillips ML; Paulson JC; Anderson DC; Greenfield LJ
J Surg Res; 1996 Jul; 64(1):26-31. PubMed ID: 8806469
[TBL] [Abstract][Full Text] [Related]
10. DHDMIQK(KAP): a novel nano-delivery system of dihydroxyl-tetrahydro-isoquinoline-3-carboxylic acid and KPAK towards the thrombus.
Feng Q; Zhao M; Gan T; Zhu H; Wang Y; Zhao S; Wang Y; Wu J; Peng S
J Mater Chem B; 2016 Sep; 4(36):5991-6003. PubMed ID: 32263488
[TBL] [Abstract][Full Text] [Related]
11. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
[TBL] [Abstract][Full Text] [Related]
12. Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
Lindenblatt N; Schareck W; Belusa L; Nickels RM; Menger MD; Vollmar B
Thromb Haemost; 2003 Nov; 90(5):882-92. PubMed ID: 14597984
[TBL] [Abstract][Full Text] [Related]
13. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.
Fägerstam JP; Whiss PA; Ström M; Andersson RG
Inflamm Res; 2000 Sep; 49(9):466-72. PubMed ID: 11071121
[TBL] [Abstract][Full Text] [Related]
14. Variations in inflammatory markers in acute myocardial infarction: a longitudinal study.
Napoleão P; Santos MC; Selas M; Viegas-Crespo AM; Pinheiro T; Ferreira RC
Rev Port Cardiol; 2007 Dec; 26(12):1357-63. PubMed ID: 18338665
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway.
Wyble CW; Hynes KL; Kuchibhotla J; Marcus BC; Hallahan D; Gewertz BL
J Surg Res; 1997 Dec; 73(2):107-12. PubMed ID: 9441802
[TBL] [Abstract][Full Text] [Related]
16. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
17. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
18. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
[TBL] [Abstract][Full Text] [Related]
19. Expression of E- and P-selectin in tumor necrosis factor-induced dermatitis in dogs.
Tremblay C; Paradis M; Doré M
Vet Pathol; 2001 May; 38(3):261-8. PubMed ID: 11355655
[TBL] [Abstract][Full Text] [Related]
20. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis.
Chen M; Geng JG
Arch Immunol Ther Exp (Warsz); 2006; 54(2):75-84. PubMed ID: 16648968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
